Shanghai Omni Pharmaceutical Co.
Latest round
- Series D
Last raised
- Nov 2024
Total raised
- Undisclosed
Investors
- 13
About Shanghai Omni Pharmaceutical Co.
, Ltd operates as an innovative pharmaceutical company that focuses on the development of respiratory preparation. The company has a proprietary design platform incorporating breathing apparatus. The company's marketing network includes hospitals, retail pharmacies and e-commerce platforms. Kai Zhang, the chairman of the company, was formerly the director of product development at IVAX Corporation. The company's main business is respiratory drug delivery technology and innovative drug research and development. Products include metered dose inhaler, dry powder inhaler, inhaled nebulizing solutions and nasal spry. The dry powder formulation project has been designated the National Key Science and Technology project, and received government support. Also, other projects have entered the clinical trial stage. Products can treat asthma and chronic obstructive pneumonia (COPD). The company generates revenue by providing respiratory preparation and related products.
Who invested in Shanghai Omni Pharmaceutical Co.
13 investors across 5 rounds
See all investors in Shanghai Omni Pharmaceutical Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shanghai Omni Pharmaceutical Co.
Who invested in Shanghai Omni Pharmaceutical Co.?
Shanghai Omni Pharmaceutical Co. has 13 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Omni Pharmaceutical Co. raised?
Shanghai Omni Pharmaceutical Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Shanghai Omni Pharmaceutical Co. last raise money?
Shanghai Omni Pharmaceutical Co.'s most recent round on record is a Series D, in Nov 2024.
What does Shanghai Omni Pharmaceutical Co. do?
, Ltd operates as an innovative pharmaceutical company that focuses on the development of respiratory preparation.
Where is Shanghai Omni Pharmaceutical Co. headquartered?
Shanghai Omni Pharmaceutical Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Omni Pharmaceutical Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Shanghai Omni Pharmaceutical Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Shanghai Omni Pharmaceutical Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.